Kepler Cheuvreux (Suisse) SA has disclosed its latest investment holdings in a recent filing with the Securities and Exchange Commission (SEC). The report, filed on October 20, 2026, outlines the firm's investment strategy and positions as of September 30, 2026. This update is particularly important for understanding the firm's approach to asset management and its response to market dynamics.
Kepler Cheuvreux is an investment management firm that specializes in providing financial services. The firm operates under the CIK number 0002096459 and is incorporated in Switzerland. Its recent filings include a variety of forms, with the latest being a 13F-HR, which details the firm's holdings and investment strategies. The firm has a fiscal year that ends on December 31.
The filing reveals that Kepler Cheuvreux reported a total of $1,645,881,559 in holdings across 234 different positions. Notably, the firm has included Unigestion UK as another manager in its reporting. The SEC filing indicates that the firm is actively managing its portfolio and making strategic investments in various sectors.
Among the notable holdings, Kepler Cheuvreux has invested in companies like AbbVie Inc, Advanced Micro Devices, and Alphabet Inc. These investments reflect a diverse strategy that spans multiple industries, including healthcare, technology, and consumer goods. The firm’s significant stake in these companies indicates its confidence in their growth potential and market positioning.
The impact of this filing may extend to various stakeholders, including investors, analysts, and competitors in the investment management sector. As firms like Kepler Cheuvreux disclose their holdings, it provides insights into market trends and investment strategies that can influence broader market movements. Competitors will likely analyze these disclosures to adjust their own strategies in response to Kepler Cheuvreux's positioning.
Looking ahead, it remains to be seen how Kepler Cheuvreux will continue to adapt its investment strategies in response to evolving market conditions. The filing does not specify any upcoming actions or changes, leaving stakeholders anticipating further updates in the future.